$ETHV

VanEck Ethereum ETF Q2 2026: NAV decline, net assets down $25.8M — 10-Q Summary

VanEck Ethereum ETF (ETHV) reported Q2 2026 net assets from operations of -$25.8M, and -$70.6M for the first six months ended June 30, 2026, citing Ether price declines and net redemptions. NAV per share fell to $23.23 from $36.41 a year earlier. Assets under management fell 50.6% YTD to $77.8M.

Original reporting
Published Aug 13, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
VanEck Ethereum ETF Q2 2026: NAV decline, net assets down $25.8M — 10-Q Summary — source image
Decision brief

The 30-second read

$ETHVBearishMed
01

Why it matters

The disclosed NAV per share decline, net assets from operations deterioration, and net redemptions provide a concrete read-through on investor flows and valuation pressure for an ETH-linked ETF.

02

Market read

Traders can use the filing’s quantified NAV/AUM/share-count changes to gauge flow and valuation pressure in an ETH-linked ETF wrapper.

03

What to watch

Fee waivers by the sponsor may cushion cash outflows, so the NAV decline is not purely mechanical from ETH price; flow-driven share reduction also matters for near-term performance.

Relevance 6/10Novelty 6/10Timing: post-market, based on Aug. 13, 2026 10-Q filing

Background

The article summarizes VanEck Ethereum ETF’s SEC 10-Q, focusing on Q2 2026 operations, NAV, and AUM changes.

Company-level read

Ticker impact

$ETHVBearishMedium confidence
Context

VanEck Ethereum ETF 10-Q reports NAV per share fell to $23.23 at June 30, 2026 from $36.41 a year ago, driven by Ether price declines and redemptions.

Expected impact

Expect continued sensitivity to ETH price and redemption flow dynamics; ETF performance likely remains pressured while ETH weakens or outflows persist.

Evidence & confidence

The filing provides specific NAV/AUM/share-count changes and attributes them to ETH price decline plus higher redemptions than creations, which directly affects ETF valuation and investor demand.

Market effects

Highlights how spot-ETH exposure vehicles can see NAV compression and outflows when ETH sells off, reinforcing flow sensitivity in crypto ETF wrappers.

Primarily US-listed crypto-ETF sentiment, with limited direct regional spillover beyond investor positioning.

Reflects global ETH price weakness translating into ETF NAV and AUM declines, reinforcing cross-market crypto risk appetite.

Counterpoint

If ETH stabilizes, the ETF’s passively tracked structure could allow NAV to recover quickly, making the reported weakness potentially transient.

Key entities

  • VanEck Ethereum ETF

    Passively tracks Ether exposure; reported NAV and AUM declines in Q2 2026 tied to ETH price weakness and net redemptions.

  • Ether (ETH)

    Primary trust holding; ETH price fell materially over the period, driving ETF performance.

Related articles

$HTZHigh

Why Is Hertz (HTZ) Stock Rocketing Higher Today

Hertz (HTZ) stock rose 5.4% after announcing a 5-year tech partnership with Verra Mobility and receiving investment-grade ratings on vehicle financing notes. The company's shares closed at $2.14, up 4.1% from the previous day. Hertz has seen significant volatility, with 61 moves greater than 5% in the past year. The stock is down 59.2% year-to-date and 72.7% below its 52-week high.

$CRWDMed

CrowdStrike Shares Pull Back From Highs: The Latest

CrowdStrike (CRWD) shares fell 4.84% to $216.92 after a 20.5% surge following strong Q2 earnings. Revenue was $1.47B, up 26% YoY, with raised full-year guidance. The decline follows SentinelOne's (S) profit guidance cut, sparking sector-wide concerns about growth and margins. CRWD remains up 101% YTD, testing its premium valuation.

$WENMed

Why Wendy's Fell This Week

Wendy's shares fell 9.3% after Trian Fund Management, its largest shareholder, reportedly ruled out a near-term buyout. The stock had risen on speculation of a takeover following disappointing earnings. Wendy's new CEO, Bob Wright, will now lead a turnaround effort. The company has a market cap of $1.49 billion and significant debt.

$AEMDHighAI 8/10

Biotech Gainers: QNRX Leads Gains As AEMD, DWTX And FRNM Report Key Developments

Aethlon Medical (AEMD) reported a 12% narrower Q1 loss and progress in its Hemopurifier study, with shares up 17.5%. Quoin Pharmaceuticals (QNRX) surged 34% pre-market on positive QRX003 data and a $50M financing. Dogwood Therapeutics (DWTX) gained 12% as its Halneuron trial advances. Freenome (FRNM) rose 7% after FDA Breakthrough Device Designation for its lung cancer test.

$AMZNMed

Amazon Jumps 4% on Expanded AWS Chip Deal: Why Is NVIDIA Falling 4%?

Amazon (AMZN) rose 4% after announcing a deal to triple its NVIDIA (NVDA) GPU order to 2 million units for AI, robotics, and agentic workloads. NVDA fell 4% amid a broader semiconductor selloff. AWS revenue grew 37% YoY to $42.23B in Q2. AMZN's capex is projected to reach $220B by 2026, with negative free cash flow of $7.6B. MSFT and GOOGL also gained 2%.